GlassScriptPhysician profile
Miranda Jo Hardee
NPI 1912151150
$8,705.49
in general payments reported to CMS, 2019-2025
49 companies · $1,689 in 2025
The $1,689 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $846 · 2021: $1,211 · 2022: $1,029 · 2023: $1,487 · 2024: $1,499 · 2025: $1,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,675.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,293.99 | 2019-2025 | |
| Janssen Biotech, INC. | $831.34 | 2019-2025 | Erleada, Balversa, Abiraterone Acetate |
| Astellas Pharma US INC | $641.64 | 2019-2025 | Xtandi, Veozah |
| Medtronic, INC. | $550.83 | 2022-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $505.96 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $502.95 | 2019-2022 | |
| Antares Pharma, INC. | $402.89 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $367.31 | 2019-2025 | |
| Olympus America INC. | $307.12 | 2024-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $239.79 | 2019-2023 | Provenge |
| Teleflex LLC | $239.00 | 2021-2025 | Urolift, Solesta, Barrigel |
| Urovant Sciences INC | $203.35 | 2021-2022 | |
| Therapeuticsmd, INC. | $173.40 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $172.07 | 2022-2025 | |
| Amgen INC. | $139.65 | 2019-2023 | Prolia |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Hardee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.